These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 8723698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.
    Grompe M, St-Louis M, Demers SI, al-Dhalimy M, Leclerc B, Tanguay RM.
    N Engl J Med; 1994 Aug 11; 331(6):353-7. PubMed ID: 8028615
    [Abstract] [Full Text] [Related]

  • 5. Rapid nonradioactive assay for the detection of the common French Canadian tyrosinemia type I mutation.
    Grompe M, al-Dhalimy M.
    Hum Mutat; 1995 Aug 11; 5(1):105. PubMed ID: 7728147
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two novel mutations involved in hereditary tyrosinemia type I.
    St-Louis M, Poudrier J, Phaneuf D, Leclerc B, Laframboise R, Tanguay RM.
    Hum Mol Genet; 1995 Feb 11; 4(2):319-20. PubMed ID: 7757089
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries.
    Bergman AJ, van den Berg IE, Brink W, Poll-The BT, Ploos van Amstel JK, Berger R.
    Hum Mutat; 1998 Feb 11; 12(1):19-26. PubMed ID: 9633815
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hereditary tyrosinemia].
    Halvorsen S.
    Ugeskr Laeger; 1979 Sep 10; 141(37):2540-1. PubMed ID: 483445
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutation analysis for prenatal diagnosis of hereditary tyrosinaemia type 1.
    Mustonen A, Ploos van Amstel HK, Berger R, Salo MK, Viinikka L, Simola KO.
    Prenat Diagn; 1997 Oct 10; 17(10):964-6. PubMed ID: 9358577
    [Abstract] [Full Text] [Related]

  • 17. Hereditary tyrosinemia type I--an overview.
    Kvittingen EA.
    Scand J Clin Lab Invest Suppl; 1986 Oct 10; 184():27-34. PubMed ID: 3296130
    [Abstract] [Full Text] [Related]

  • 18. Fumarylacetoacetase mutations in tyrosinaemia type I.
    Rootwelt H, Høie K, Berger R, Kvittingen EA.
    Hum Mutat; 1996 Oct 10; 7(3):239-43. PubMed ID: 8829657
    [Abstract] [Full Text] [Related]

  • 19. Chromosomal instability in hereditary tyrosinemia type I.
    Wilson KS, Timmons CF, Hilton DS, Weinberg AG, Tonk V.
    Pediatr Pathol; 1994 Oct 10; 14(6):1055-7. PubMed ID: 7855008
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.